Skip to content

Depression: all studies

Page 813 of 1,034: studies 8,121 to 8,130 of 10,336, newest first. Back to the depression overview

Research

A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics

Trends in Neurosciences December 21, 2020 Neil K. Savalia, Ling-Xiao Shao, Alex C. Kwan 110 citations

Pilot studies have hinted that serotonergic psychedelics such as psilocybin may relieve depression, and could possibly do so by promoting neural plasticity. Intriguingly, another psychotomimetic compound, ketamine, is a fast-acting antidepressant and induces synapse formation. The similarities in behavioral and neural effects have been puzzling because the compounds target distinct molecular...

A comparison of MDMA-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis

Journal of Psychopharmacology December 20, 2020 Benjamin Illingworth, Declan J Lewis, Andrew T Lambarth et al. 47 citations

Rationale: Novel, evidence-based treatments are required for treatment-resistant post-traumatic stress disorder (PTSD). 3,4-Methylenedioxymethamphetamine (MDMA) has beneficially augmented psychotherapy in several small clinical trials. Objective: To review the use of MDMA-assisted psychotherapy in treatment-resistant PTSD. Methods: Systematic searches of four databases were conducted from...

DOI: 10.1177/0269881120965915 (opens in new tab) MDMA Placebo Meta-analysis Randomized controlled trial +3

The MAC-P program: A pilot study of a mindfulness and compassion program for youth with psychotic experiences.

Early Intervention in Psychiatry December 19, 2020 Tara Hickey, Barnaby Nelson, Joanne Enticott et al.

Background: The purpose of this pilot study was to determine the feasibility, acceptability and the potential clinical utility of a novel mindfulness and compassion program (MAC-P) designed for youth with a range of psychotic experiences. Method: A non-randomised, non-controlled prospective follow-up study was conducted. Eighteen participants who either met criteria for the 'at risk mental...

Taming ibogaine

C&EN Global Enterprise December 18, 2020 Bethany Halford

By systematically tweaking the structure of the psychedelic compound ibogaine, chemists have created a molecule that may someday find use as a treatment for neuropsychiatric disorders, including depression and addiction. The compound, which the researchers call tabernanthalog, has a simpler structure than ibogaine, making it easier to synthesize. Researchers in David E. Olson’s lab at the...

Effects and safety of Psilocybe cubensis and Panaeolus cyanescens magic mushroom extracts on endothelin-1-induced hypertrophy and cell injury in cardiomyocytes

Scientific Reports December 18, 2020 Sanah Malomile Nkadimeng, Christiaan M.l. Steinmann, J.n. Eloff 31 citations

Abstract Prevalence of major depression in people with chronic heart failure is higher than in normal populations. Depression in heart failure has become a major issue. Psilocybin-containing mushrooms commonly known as magic mushrooms, have been used since ancient times for their mind healing properties. Their safety in cardiovascular disease conditions is not fully known and may pose as a risk...

DOI: 10.1038/s41598-020-79328-5 (opens in new tab) Full text (opens in new tab) Endothelin receptor Muscle hypertrophy Pathological Mushroom

Mental Illness through the Lens of Mindfulness

The Oxford Handbook of Meditation December 15, 2020 Patricia Lynn Dobkin, Kaveh Monshat

Abstract: The intention of this chapter is to re-envision mental illness within a paradigm that unites the biopsychosocial paradigm with a modern Buddhist spirituality, particularly associated with mindfulness. Emotion regulation, a balanced relationship with one’s self-concept, and social connection are usually regarded as essential components of well-being within both systems of thought....

Transcendental Meditation in the Treatment of Mental and Physical Conditions

The Oxford Handbook of Meditation December 15, 2020 David W. Orme-Johnson

Abstract The Transcendental Meditation technique (TM) is a process of transcending from the active mind to the silent mind, creating a feeling of well-being that many people describe as blissful. As the mind settles, the body becomes deeply rested, as indicated by reductions of physiological stress markers. The meditator typically experiences expanded inner awareness, which corresponds to...

Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients—A randomized, double‐blind, controlled clinical study

Brain and Behavior December 11, 2020 Lei Zou, S. Min, Qibin Chen et al.

We previously confirmed that low‐dose ketamine, as an adjunctive anesthetic for electroconvulsive therapy (ECT) in adult patients with depression, accelerates the effects of ECT and reduces the ECT‐induced learning and memory deficits. This study explored the efficacy and safety of low‐dose ketamine in elderly patients with depression.

Impact of a Combined Philosophy and Mindfulness Intervention on Positive and Negative Indicators of Mental Health Among Pre-kindergarten Children: Results From a Pilot and Feasibility Study.

Frontiers in Psychiatry December 11, 2020

Background: Fostering greater resiliency to stress, optimal psychosocial development and promoting better mental health and well-being in youth is an important goal of the Canadian and American elementary school systems ( 1 , 2 ). Recent research on mindfulness and philosophy for children (P4C) has yielded promising results regarding innovative interventions that may be implemented in...

Author response: Self-blinding citizen science to explore psychedelic microdosing

December 11, 2020 Balázs Szigeti, Laura Kärtner, Allan Blemings et al. 1 citation

Psychedelic psychotherapy, therapy enhanced with psychedelic drugs such as LSD or psilocybin (the active ingredient of ‘magic mushrooms’), has been suggested to improve psychological well-being. For this reason, trials on psychedelic therapy for the treatment of depression, addiction and other conditions are ongoing. Recently, ‘microdosing’ – a way of administering psychedelics that involves...